… are adopted in treatment guidelines for uncomplicated p. falciparum malaria in majority of
Sub-Saharan countries while dihydroartemisinin-piperaquine has been introduced in some …

… -line treatment for uncomplicated falciparum. The … of dihydroartemisinin–piperaquine (DHA–PQ)
and artemether–lumefantrine (AL) for the treatment of uncomplicated falciparum malaria …

… To assess the efficacy of dihydroartemisinin/piperaquine for uncomplicated P. falciparum
malaria in Gia Lai, Central Vietnam, and determine parasite resistance to artemisinin (…

… has been recommended to ensure that the persons indeed consumed the anti-malarial as
… for the treatment of uncomplicated Plasmodium falciparum and Plasmodium vivax malaria in …

… Dihydroartemisinin/piperaquine is an antimalarial … Dihydroartemisinin/piperaquine has been
frequently used in … for the treatment of uncomplicated Plasmodium falciparum malaria since …

… (AL) as the first-line treatment for uncomplicated malaria in 2004 (16). Dihydroartemisinin-piperaquine
(DP) was adopted as the second-line antimalarial in 2010. AL and DP have been …

… falciparum populations in Indonesia for … treatment for falciparum malaria, with
artemether-lumefantrine (AL), also licensed in Indonesia, for treatment of uncomplicated falciparum …

Objective The World Health Organization recommends artemisinin-based combination
therapies (ACTs) for the treatment of uncomplicated malaria to improve the therapeutic efficacy …

… ALU and DHP have retained a high efficacy in the treatment of uncomplicated plasmodium
falciparum malaria. Age and parasite density were strong predictors for persistent day 1 …

… against uncomplicated P. falciparum and CQ or DHA/PPQ against uncomplicated P. vivax to
… on-going, evidence-based recommendations for the national malaria treatment guidelines. …